Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
A commission baked into a funding agreement in a class action against Mayne Pharma is under threat, with a judge mulling an order off his own bat to cut the rate.
Australian Clinical Labs may seek to strike out part of the OAIC’s case over a 2022 data breach, arguing it would unfairly allow the watchdog to allege both single and multiple contraventions of privacy law.
The competition regulator has given its blessing to the $8.8 billion merger of Chemist Warehouse and Sigma Healthcare, subject to a promise that franchisees will be free to terminate their contracts.
The ACCC has red flags about the acquisition of Japanese healthcare business I’rom Group by private equity behemoth Blackstone.
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
A class action over deaths allegedly caused by negligent care at a NSW aged care facility during COVID-19 has settled.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
A judge has ordered Victoria’s Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.
A ninth class action has been filed on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after two landmark wins in the Gordon Legal-led underpayments class actions.